| NCT04199689 |
Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049) |
https://ClinicalTrials.gov/show/NCT04199689 |
Recruiting |
Merck Sharp & Dohme Corp. |
2024-07-15 |
| NCT04015336 |
E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT04015336 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2023-04-28 |
| NCT04133610 |
HPVPro Study: Comparison of HPV Detection in Clinician-collected Cervical Swabs and Self-sampled Cervicovaginal Swabs |
https://ClinicalTrials.gov/show/NCT04133610 |
Completed |
The Institute of Molecular and Translational Medicine, Czech Republic |
2019-10-30 |
| NCT03302858 |
A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRXâ„¢ Anorectal Wand |
https://ClinicalTrials.gov/show/NCT03302858 |
Recruiting |
Laser Surgery Care |
2019-10-31 |
| NCT03284866 |
HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV |
https://ClinicalTrials.gov/show/NCT03284866 |
Active, not recruiting |
AIDS Malignancy Consortium |
2022-01-31 |
| NCT03202992 |
Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection |
https://ClinicalTrials.gov/show/NCT03202992 |
Completed |
Antiva Biosciences |
2019-02-04 |
| NCT03180034 |
Scientific Evaluation of One or Two Doses of the Bivalent or Nonavalent Prophylactic HPV Vaccines |
https://ClinicalTrials.gov/show/NCT03180034 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
2022-12-31 |
| NCT03158220 |
Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004) |
https://ClinicalTrials.gov/show/NCT03158220 |
Completed |
Merck Sharp & Dohme Corp. |
2018-11-19 |
| NCT03085381 |
A Phase I Study of Quadrivalent HPV Recombinant Vaccine |
https://ClinicalTrials.gov/show/NCT03085381 |
Completed |
Shanghai Bovax Biotechnology Co., Ltd. |
2017-10-31 |
| NCT03032575 |
Anal HPV Infection and Risk for Anal High-grade Squamous Intraepithelial Lesion Among Thai MSM With Acute HIV Infection |
https://ClinicalTrials.gov/show/NCT03032575 |
Recruiting |
Thai Red Cross AIDS Research Centre |
2020-12-31 |
| NCT02862795 |
Human Papillomavirus Anal Infection |
https://ClinicalTrials.gov/show/NCT02862795 |
Completed |
Centre Hospitalier Universitaire de Besancon |
2016-06-30 |
| NCT02845739 |
PApillomavirus in REnal Transplant Patient |
https://ClinicalTrials.gov/show/NCT02845739 |
Completed |
Centre Hospitalier Universitaire de Besancon |
2017-11-10 |
| NCT02827838 |
Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer |
https://ClinicalTrials.gov/show/NCT02827838 |
Recruiting |
Wake Forest University Health Sciences |
2020-08-31 |
| NCT02816879 |
Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men |
https://ClinicalTrials.gov/show/NCT02816879 |
Active, not recruiting |
Jonsson Comprehensive Cancer Center |
2020-07-31 |
| NCT02811367 |
The HPV Self-test as a Test of Cure in Madagascar |
https://ClinicalTrials.gov/show/NCT02811367 |
Completed |
University Hospital, Geneva |
2016-09-30 |
| NCT02785289 |
A Comparison of Cotton and Flocked Swabs for Vaginal Self Collection |
https://ClinicalTrials.gov/show/NCT02785289 |
Completed |
University Hospital, Geneva |
2016-09-30 |
| NCT02774538 |
Agreement Between Oral and Cervical Human Papillomavirus Infection in a French Cohort |
https://ClinicalTrials.gov/show/NCT02774538 |
Recruiting |
Institut de Cancérologie de Lorraine |
2021-05-31 |
| NCT02733068 |
A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine. |
https://ClinicalTrials.gov/show/NCT02733068 |
Active, not recruiting |
Shanghai Zerun Biotechnology Co.,Ltd |
2018-12-31 |
| NCT02632344 |
Pembrolizumab for HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal and/or Pulmonary Involvement |
https://ClinicalTrials.gov/show/NCT02632344 |
Active, not recruiting |
Massachusetts General Hospital |
2020-10-31 |
| NCT02592902 |
Recurrent Respiratory Papillomatosis and Extraesophageal Reflux |
https://ClinicalTrials.gov/show/NCT02592902 |
Completed |
University Hospital Ostrava |
2018-08-31 |
| NCT02576054 |
Safety and Tolerability Study of V501 in Japanese Boys (V501-200) |
https://ClinicalTrials.gov/show/NCT02576054 |
Completed |
Merck Sharp & Dohme Corp. |
2018-08-08 |
| NCT02558803 |
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3 |
https://ClinicalTrials.gov/show/NCT02558803 |
Completed |
Regenstrief Institute, Inc. |
2016-05-31 |
| NCT02858310 |
E7 TCR T Cells for Human Papillomavirus-Associated Cancers |
https://ClinicalTrials.gov/show/NCT02858310 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2020-12-31 |
| NCT03391921 |
Vaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study) |
https://ClinicalTrials.gov/show/NCT03391921 |
Recruiting |
Centre Hospitalier Universitaire Saint Pierre |
2020-01-08 |
| NCT02551887 |
HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts |
https://ClinicalTrials.gov/show/NCT02551887 |
Completed |
Regenstrief Institute, Inc. |
2015-04-30 |
| NCT02546752 |
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine |
https://ClinicalTrials.gov/show/NCT02546752 |
Completed |
Regenstrief Institute, Inc. |
2016-05-31 |
| NCT02535104 |
Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV) |
https://ClinicalTrials.gov/show/NCT02535104 |
Completed |
Tamir Biotechnology, Inc. |
2016-09-30 |
| NCT02464358 |
An Information-Motivation-Behavioral Skills (IMB) Intervention to Promote Human Papillomavirus Vaccination Among Women |
https://ClinicalTrials.gov/show/NCT02464358 |
Completed |
University of Connecticut |
2012-10-31 |
| NCT02460237 |
HPV Self-Test Intervention in Ohio Appalachia |
https://ClinicalTrials.gov/show/NCT02460237 |
Completed |
Ohio State University Comprehensive Cancer Center |
2016-06-14 |
| NCT02405533 |
Phase II Evaluation of AHCC for the Eradication of HPV Infections |
https://ClinicalTrials.gov/show/NCT02405533 |
Active, not recruiting |
The University of Texas Health Science Center, Houston |
2019-02-28 |
| NCT02354144 |
Lubricant Investigation in Men to Inhibit Transmission of HPV Infection |
https://ClinicalTrials.gov/show/NCT02354144 |
Recruiting |
McGill University |
2020-10-31 |
| NCT02346227 |
Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix |
https://ClinicalTrials.gov/show/NCT02346227 |
Completed |
Universiteit Antwerpen |
2018-08-31 |
| NCT02304770 |
Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia |
https://ClinicalTrials.gov/show/NCT02304770 |
Completed |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. |
2017-01-31 |
| NCT02287961 |
Human Papillomavirus Infection and Related Anal Lesions in HIV-positive Men Who Have Sex With Men |
https://ClinicalTrials.gov/show/NCT02287961 |
Active, not recruiting |
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) |
2021-06-30 |
| NCT02263378 |
A New Supplement for the Immune Response to HPV Infection |
https://ClinicalTrials.gov/show/NCT02263378 |
Completed |
University of Messina |
2016-03-31 |
| NCT02258659 |
Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT02258659 |
Active, not recruiting |
University of Chicago |
2018-12-31 |
| NCT02124252 |
Community-Driven Cervical Cancer Prevention in Western Kenya |
https://ClinicalTrials.gov/show/NCT02124252 |
Completed |
Duke University |
2016-10-31 |
| NCT02114385 |
A Study to Compare Immune Response of V503 to Gardasil in 16- to 26-year-old Men (V503-020) |
https://ClinicalTrials.gov/show/NCT02114385 |
Completed |
Merck Sharp & Dohme Corp. |
2015-04-22 |
| NCT02067507 |
Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles County |
https://ClinicalTrials.gov/show/NCT02067507 |
Completed |
University of California, Los Angeles |
2019-10-31 |
| NCT02065973 |
An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101 |
https://ClinicalTrials.gov/show/NCT02065973 |
Completed |
PDS Biotechnology Corp. |
2015-12-30 |
| NCT02048020 |
Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer |
https://ClinicalTrials.gov/show/NCT02048020 |
Completed |
Jonsson Comprehensive Cancer Center |
2017-01-09 |
| NCT03929172 |
A Study of Safety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female Subjects |
https://ClinicalTrials.gov/show/NCT03929172 |
Completed |
2A Pharma AB |
2020-05-29 |
| NCT02009800 |
ICI-VPH: Impact of HPV Immunisation Schedules Against HPV |
https://ClinicalTrials.gov/show/NCT02009800 |
Active, not recruiting |
CHU de Quebec-Universite Laval |
2021-12-31 |
| NCT01984697 |
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010) |
https://ClinicalTrials.gov/show/NCT01984697 |
Completed |
Merck Sharp & Dohme Corp. |
2015-06-19 |
| NCT01946139 |
Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV |
https://ClinicalTrials.gov/show/NCT01946139 |
Completed |
AIDS Malignancy Consortium |
2018-10-31 |
| NCT01932697 |
Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT01932697 |
Active, not recruiting |
Mayo Clinic |
2016-10-20 |
| NCT01924117 |
Genotypification and Predisposing Factors in Human Papilloma Virus Infection |
https://ClinicalTrials.gov/show/NCT01924117 |
Completed |
Materno-Perinatal Hospital of the State of Mexico |
2011-05-31 |
| NCT01901770 |
The Parents in Appalachia Receive Education Needed for Teen Project |
https://ClinicalTrials.gov/show/NCT01901770 |
Active, not recruiting |
Ohio State University Comprehensive Cancer Center |
2020-12-31 |
| NCT01898494 |
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT01898494 |
Active, not recruiting |
Eastern Cooperative Oncology Group |
2020-02-29 |
| NCT01862874 |
Efficacy and Tolerability Study of V501 in Japanese Males (V501-122) |
https://ClinicalTrials.gov/show/NCT01862874 |
Completed |
Merck Sharp & Dohme Corp. |
2017-08-30 |
| NCT01824992 |
Recombinant Human Interferon a-2b Gel for HPV Gynecological Infections |
https://ClinicalTrials.gov/show/NCT01824992 |
Completed |
Lee’s Pharmaceutical Limited |
2012-03-31 |
| NCT01824537 |
Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study |
https://ClinicalTrials.gov/show/NCT01824537 |
Recruiting |
McGill University |
2020-09-30 |
| NCT01693783 |
Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer |
https://ClinicalTrials.gov/show/NCT01693783 |
Active, not recruiting |
National Cancer Institute (NCI) |
2020-12-31 |
| NCT01588301 |
Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention |
https://ClinicalTrials.gov/show/NCT01588301 |
Completed |
University Hospital, Tours |
2012-12-31 |
| NCT01571141 |
Polyhexamethylene Biguanide Increases the Regression Rate of Human Papillomavirus (HPV) Infection |
https://ClinicalTrials.gov/show/NCT01571141 |
Completed |
AGUNCO Obstetrics and Gynecology Centre |
NA |
| NCT01550783 |
Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening |
https://ClinicalTrials.gov/show/NCT01550783 |
Completed |
University of Washington |
2017-11-16 |
| NCT01532102 |
Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts |
https://ClinicalTrials.gov/show/NCT01532102 |
Completed |
Vaxart |
2013-05-06 |
| NCT01492582 |
Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors |
https://ClinicalTrials.gov/show/NCT01492582 |
Active, not recruiting |
University of Alabama at Birmingham |
2019-02-08 |
| NCT01375868 |
Effect of Vaccination in Patients With Recurrent Respiratory Papillomatosis |
https://ClinicalTrials.gov/show/NCT01375868 |
Completed |
Institute of Hematology and Blood Transfusion, Czech Republic |
2018-12-31 |
| NCT04438291 |
Effects of a HPV Vaccination Health-promotion Programme on Improving Vaccine Acceptance and Uptake Among Female Adolescents |
https://ClinicalTrials.gov/show/NCT04438291 |
Recruiting |
Chinese University of Hong Kong |
2022-01-31 |
| NCT04436133 |
Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) |
https://ClinicalTrials.gov/show/NCT04436133 |
Recruiting |
National Vaccine and Serum Institute, China |
2021-01-22 |
| NCT04398433 |
INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP) |
https://ClinicalTrials.gov/show/NCT04398433 |
Recruiting |
Inovio Pharmaceuticals |
2023-07-31 |
| NCT04333212 |
HPV Genotyping by DR. HPV Genotyping in Vitro Diagnostic Device (IVD) Kit in Exfoliated Cells of the Uterine Cervix |
https://ClinicalTrials.gov/show/NCT04333212 |
Completed |
Chang Gung Memorial Hospital |
2013-12-30 |
| NCT04278326 |
Primary Organoid Models and Combined Nucleic Acids Therapeutics for Anti-HPV Treatments |
https://ClinicalTrials.gov/show/NCT04278326 |
Recruiting |
Centre Hospitalier Régional d’Orléans |
2024-04-30 |
| NCT04270773 |
Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women |
https://ClinicalTrials.gov/show/NCT04270773 |
Recruiting |
University Hospital Virgen de las Nieves |
2022-07-30 |
| NCT04247282 |
Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection |
https://ClinicalTrials.gov/show/NCT04247282 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2022-08-31 |
| NCT04226313 |
Self-sampling for Non-attenders to Cervical Cancer Screening |
https://ClinicalTrials.gov/show/NCT04226313 |
Recruiting |
The Institute of Molecular and Translational Medicine, Czech Republic |
2020-12-01 |
| NCT04210336 |
Clinical Trial to Evaluate Papilocare® Gel Efficacy Into Repairment of Cervical Lesions Caused by HPV |
https://ClinicalTrials.gov/show/NCT04210336 |
Recruiting |
Procare Health Iberia S.L. |
2020-08-31 |
| NCT04199078 |
Clinical Trial to Explore Papilocare Gel Efficacy to Repair of the Cervico-vaginal Mucosa With HPV High Risk Lesions. |
https://ClinicalTrials.gov/show/NCT04199078 |
Recruiting |
Procare Health Iberia S.L. |
2020-06-30 |
| NCT04191967 |
Thermocoagulation for Treatment of Precancerous Cervical Lesions |
https://ClinicalTrials.gov/show/NCT04191967 |
Recruiting |
University of California, San Francisco |
2020-12-31 |
| NCT04124198 |
Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT04124198 |
Recruiting |
Rigshospitalet, Denmark |
2024-01-31 |
| NCT04083196 |
A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years |
https://ClinicalTrials.gov/show/NCT04083196 |
Recruiting |
National Vaccine and Serum Institute, China |
2021-03-12 |
| NCT04072913 |
Matrix Metalloproteinases and Human Papillomavirus in Dysplasias and Cancers of the Cervix |
https://ClinicalTrials.gov/show/NCT04072913 |
Completed |
University Hospital, Bordeaux |
2011-01-31 |
| NCT04002154 |
Clinical Trial to Explore the Papilocare Gel Efficacy to Repair the Cervico-vaginal Mucosa With Lesions Caused by HPV |
https://ClinicalTrials.gov/show/NCT04002154 |
Completed |
Procare Health Iberia S.L. |
2018-07-31 |
| NCT04000503 |
Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge) |
https://ClinicalTrials.gov/show/NCT04000503 |
Recruiting |
University of British Columbia |
2021-12-31 |
| NCT03998254 |
Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023) |
https://ClinicalTrials.gov/show/NCT03998254 |
Active, not recruiting |
Merck Sharp & Dohme Corp. |
2027-02-01 |
| NCT03981822 |
A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts |
https://ClinicalTrials.gov/show/NCT03981822 |
Recruiting |
Verrica Pharmaceuticals Inc. |
2020-08-12 |
| NCT03903562 |
Immunobridging Study of 9- Valent Human Papillomavirus (9vHPV) Vaccine (V503) in Chinese Females 9 to 45 Years of Age (V503-024) |
https://ClinicalTrials.gov/show/NCT03903562 |
Active, not recruiting |
Merck Sharp & Dohme Corp. |
2020-07-31 |
| NCT03900572 |
A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine |
https://ClinicalTrials.gov/show/NCT03900572 |
Recruiting |
Shanghai Zerun Biotechnology Co.,Ltd |
2020-04-30 |
| NCT03898167 |
Prospective Evaluation of Self-Testing to Increase Screening |
https://ClinicalTrials.gov/show/NCT03898167 |
Enrolling by invitation |
Baylor College of Medicine |
2023-02-28 |
| NCT03726151 |
Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs |
https://ClinicalTrials.gov/show/NCT03726151 |
Enrolling by invitation |
University of California, Los Angeles |
2022-10-31 |
| NCT03346915 |
Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention |
https://ClinicalTrials.gov/show/NCT03346915 |
Completed |
Boston Medical Center |
2019-04-19 |
| NCT03707587 |
M7824 in People With Recurrent Respiratory Papillomatosis |
https://ClinicalTrials.gov/show/NCT03707587 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
2020-07-07 |
| NCT03675256 |
The KEN SHE Study on HPV-vaccine Efficacy |
https://ClinicalTrials.gov/show/NCT03675256 |
Active, not recruiting |
University of Washington |
2022-11-15 |
| NCT03610581 |
Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix |
https://ClinicalTrials.gov/show/NCT03610581 |
Recruiting |
Janssen Vaccines & Prevention B.V. |
2020-08-09 |
| NCT03584308 |
Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus Esophageal |
https://ClinicalTrials.gov/show/NCT03584308 |
Completed |
Catalysis SL |
2018-05-15 |
| NCT03546842 |
Safety and Immunogenicity Study of V503 (GARDASILâ„¢9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017) |
https://ClinicalTrials.gov/show/NCT03546842 |
Completed |
Merck Sharp & Dohme Corp. |
2019-01-29 |
| NCT03510091 |
Video-Assisted Counseling for HPV Vaccination |
https://ClinicalTrials.gov/show/NCT03510091 |
Recruiting |
Le Bonheur Children’s Hospital |
2018-11-30 |
| NCT03487549 |
Cantharidin and Occlusion in Verruca Epithelium |
https://ClinicalTrials.gov/show/NCT03487549 |
Completed |
Verrica Pharmaceuticals Inc. |
2019-05-16 |
| NCT03442062 |
Quality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination |
https://ClinicalTrials.gov/show/NCT03442062 |
Completed |
University of North Carolina, Chapel Hill |
2020-04-30 |
| NCT01254643 |
A Study of the Safety, Tolerability, and Immunogenicity of a 9-valent Human Papillomavirus Vaccine ([9vHPV]; V503) Administered to 9- to 15-Year-Old Japanese Girls (V503-008). |
https://ClinicalTrials.gov/show/NCT01254643 |
Completed |
Merck Sharp & Dohme Corp. |
2013-08-10 |
| NCT01245764 |
GARDASILâ„¢ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046) |
https://ClinicalTrials.gov/show/NCT01245764 |
Completed |
Merck Sharp & Dohme Corp. |
2013-04-15 |
| NCT01104181 |
Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test |
https://ClinicalTrials.gov/show/NCT01104181 |
Completed |
Laser Surgery Care |
2010-12-31 |
| NCT01073293 |
A Study of V503 Vaccine Given Concomitantly With REPEVAXâ„¢ in 11 to 15 Year Olds (V503-007) |
https://ClinicalTrials.gov/show/NCT01073293 |
Completed |
Merck Sharp & Dohme Corp. |
2011-06-16 |
| NCT01020747 |
Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP) |
https://ClinicalTrials.gov/show/NCT01020747 |
Completed |
Massachusetts General Hospital |
2011-03-31 |
| NCT00988884 |
A Study of V503 Given Concomitantly With Menactraâ„¢ and Adacelâ„¢ in 11 to 15 Year Olds (V503-005) |
https://ClinicalTrials.gov/show/NCT00988884 |
Completed |
Merck Sharp & Dohme Corp. |
2011-02-22 |
| NCT00973856 |
Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands |
https://ClinicalTrials.gov/show/NCT00973856 |
Completed |
Akron General Medical Center |
2011-12-31 |
| NCT00973362 |
Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System |
https://ClinicalTrials.gov/show/NCT00973362 |
Completed |
Gen-Probe, Incorporated |
2013-06-30 |
| NCT00956553 |
Reactogenicity Study of Cervarix and Gardasil in UK Adolescent Girls |
https://ClinicalTrials.gov/show/NCT00956553 |
Completed |
Public Health England |
2012-09-30 |
| NCT00943722 |
A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002) |
https://ClinicalTrials.gov/show/NCT00943722 |
Active, not recruiting |
Merck Sharp & Dohme Corp. |
2011-04-30 |
| NCT00925288 |
Acceptability of Human Papillomavirus (HPV) Vaccine in Female Sex Workers |
https://ClinicalTrials.gov/show/NCT00925288 |
Completed |
Johns Hopkins Bloomberg School of Public Health |
2011-08-31 |
| NCT04369339 |
Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal Cytology |
https://ClinicalTrials.gov/show/NCT04369339 |
Completed |
Bezmialem Vakif University |
2019-10-01 |
| NCT03345875 |
Feasibility and Acceptability of HPV Self-Collection Cervical Cancer Screening and Treatment in Botswana |
https://ClinicalTrials.gov/show/NCT03345875 |
Completed |
Jhpiego |
2018-06-30 |
| NCT00834106 |
Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041) |
https://ClinicalTrials.gov/show/NCT00834106 |
Completed |
Merck Sharp & Dohme Corp. |
2012-05-11 |
| NCT02631863 |
Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1) |
https://ClinicalTrials.gov/show/NCT02631863 |
Completed |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. |
2018-11-24 |
| NCT02859454 |
Avelumab for People With Recurrent Respiratory Papillomatosis |
https://ClinicalTrials.gov/show/NCT02859454 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
2018-06-30 |
| NCT00685412 |
Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3 |
https://ClinicalTrials.gov/show/NCT00685412 |
Completed |
Inovio Pharmaceuticals |
2011-01-31 |
| NCT00635830 |
An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035) |
https://ClinicalTrials.gov/show/NCT00635830 |
Completed |
Merck Sharp & Dohme Corp. |
2008-04-30 |
| NCT00572832 |
Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting |
https://ClinicalTrials.gov/show/NCT00572832 |
Completed |
University of Pittsburgh |
2009-04-30 |
| NCT00571701 |
Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis |
https://ClinicalTrials.gov/show/NCT00571701 |
Completed |
Northwell Health |
2015-01-31 |
| NCT00551187 |
A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00551187 |
Completed |
Merck Sharp & Dohme Corp. |
2009-05-31 |
| NCT00543543 |
Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001) |
https://ClinicalTrials.gov/show/NCT00543543 |
Completed |
Merck Sharp & Dohme Corp. |
2013-04-10 |
| NCT00520598 |
Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001) |
https://ClinicalTrials.gov/show/NCT00520598 |
Completed |
Merck Sharp & Dohme Corp. |
2011-05-31 |
| NCT00518180 |
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents |
https://ClinicalTrials.gov/show/NCT00518180 |
Completed |
Novartis |
2008-04-30 |
| NCT00496626 |
An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects (V501-030)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00496626 |
Completed |
Merck Sharp & Dohme Corp. |
2009-02-28 |
| NCT00411749 |
V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028) |
https://ClinicalTrials.gov/show/NCT00411749 |
Completed |
Merck Sharp & Dohme Corp. |
2009-09-18 |
| NCT00380367 |
Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029) |
https://ClinicalTrials.gov/show/NCT00380367 |
Completed |
Merck Sharp & Dohme Corp. |
2008-02-04 |
| NCT00378560 |
V501 Efficacy Study in Women Aged 18 to 26 (V501-027) |
https://ClinicalTrials.gov/show/NCT00378560 |
Completed |
Merck Sharp & Dohme Corp. |
2009-09-16 |
| NCT00365716 |
Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00365716 |
Completed |
Merck Sharp & Dohme Corp. |
2004-05-31 |
| NCT00316706 |
Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals’ (GSK Bio) HPV-16/18 Vaccine |
https://ClinicalTrials.gov/show/NCT00316706 |
Completed |
GlaxoSmithKline |
2009-01-31 |
| NCT00303823 |
Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia |
https://ClinicalTrials.gov/show/NCT00303823 |
Completed |
National Cancer Institute (NCI) |
2010-11-30 |
| NCT00205374 |
Use of Cidofovir for Recurrent Respiratory Papillomatosis |
https://ClinicalTrials.gov/show/NCT00205374 |
Completed |
University of Wisconsin, Madison |
2009-12-31 |
| NCT00157950 |
Human Papillomavirus (HPV) Registration Study (Gardasil)(V501-023)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00157950 |
Completed |
Merck Sharp & Dohme Corp. |
2006-06-30 |
| NCT00092547 |
A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018) |
https://ClinicalTrials.gov/show/NCT00092547 |
Completed |
Merck Sharp & Dohme Corp. |
2005-11-03 |
| NCT00090220 |
A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019) |
https://ClinicalTrials.gov/show/NCT00090220 |
Completed |
Merck Sharp & Dohme Corp. |
2009-05-21 |
| NCT00054041 |
Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia |
https://ClinicalTrials.gov/show/NCT00054041 |
Completed |
National Cancer Institute (NCI) |
2007-01-31 |
| NCT00038714 |
A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis |
https://ClinicalTrials.gov/show/NCT00038714 |
Completed |
Nventa Biopharmaceuticals Corporation |
NA |
| NCT00000764 |
Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection. |
https://ClinicalTrials.gov/show/NCT00000764 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |